Effect of allopurinol in preventing kidney damage due to coronary angiography
Not Applicable
- Conditions
- contrast induced nephropathy.X-ray contrast media
- Registration Number
- IRCT2015120525372N1
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
All patients undergoing elective PCI
Exclusion criteria: Patients who are candidates for CABG or primary PCI; Patients with gout or prior use of allopurinol; Serum creatinin >3mg/dL or eGFR<60ml/min; Advanced hepatic failure; Patients who are using azathioprine, 6MP, or warfarin; Patients who have not filled/signed consent form, or the ones who had shown adverse reaction to the drug in prior use
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serum cystatin C. Timepoint: 24 hours after PCI. Method of measurement: blood sample.;Serum creatinin. Timepoint: 24 hours after PCI. Method of measurement: blood sample.
- Secondary Outcome Measures
Name Time Method Serum uric acid. Timepoint: 24 hours before and after PCI. Method of measurement: blood sample.